PRESS RELEASE published on 02/21/2024 at 14:15, 2 years 5 months ago Biotricity Strengthens its Foundation for Growth, Achieves Lower Cost of Sales, Expanding Margins of 73% and Increased Device Sales, for Third Quarter of Fiscal Year 2024 Biotricity Inc. reports Q3FY24 financial results showing topline growth, increased subscription revenue, improved margins, lower costs, and a stronger path to breakeven in the remote cardiac monitor sector of consumer healthcare Healthcare Biotricity Inc. Q3FY24 Financial Results Subscription Revenue Remote Cardiac Monitor
BRIEF published on 02/21/2024 at 14:15, 2 years 5 months ago Biotricity Inc. announces growth with a significant increase in subscriptions for the third quarter of the 2024 fiscal year Financial Results Revenue Growth Biotricity Inc. Remote Cardiac Monitoring Technological Subscriptions
PRESS RELEASE published on 02/19/2024 at 14:00, 2 years 5 months ago Biotricity to Host Third Quarter Fiscal Year 2024 Financial Results and Business Update Call on February 21st Biotricity Inc. to host Third Quarter FY 2024 Financial Results and Business Update Call on February 21, 2024, featuring Founder Dr. Waqaas Al-Siddiq and CFO John Ayanoglou. Event details and webcast information provided Financial Results Business Update Biotricity Inc. Investor Call Remote Health Monitoring
PRESS RELEASE published on 02/14/2024 at 14:00, 2 years 5 months ago Biotricity Advances Towards Breakeven Milestone - Set to Announce Record Margins and Operational Efficiency for Third Quarter of Fiscal Year 2024 Biotricity Inc. continues its shift to subscription-based revenue, emphasizing margin improvement and operational efficiency enhancements. Company to announce Third Quarter Fiscal 2024 Results on February 20, 2024 Operational Efficiency Biotricity Inc. Subscription-based Revenue Margin Improvement Third Quarter Fiscal 2024 Results
PRESS RELEASE published on 01/23/2024 at 14:15, 2 years 6 months ago Biotricity Expands Development of its Cardiac AI Cloud Platform with Data Ecosystem of over 360 billion Heartbeats Biotricity Inc. (NASDAQ:BTCY) has announced the expansion of its Cardiac AI Cloud platform, aiming to develop predictive monitoring to identify issues before they occur, supporting earlier interventions, and reducing healthcare costs. The company's goal is to build comprehensive AI models for improved diagnoses and interventions, having analyzed over 360 billion heartbeats and helped diagnose over 200,000 patients. The development of large data models is crucial for supporting the intermittent nature of cardiac issues and the noisy data arising from ambulatory monitoring, and for helping cardiologists service more patients. The company's effort in building a comprehensive Cardiac AI Cloud platform aims to make cardiac care accessible, affordable, and scalable, thus providing necessary support and assistance to healthcare professionals. For more information, visit www.biotricity.com. Biotricity Inc. Cardiac AI Cloud Platform Predictive Monitoring Healthcare Costs Comprehensive AI Models
Published on 08/03/2026 at 23:00, 3 hours 1 minute ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 3 days ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 3 days ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days 1 hour ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 23:33, 2 hours 27 minutes ago EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 2 hours 40 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 4 hours 21 minutes ago PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 6 hours 25 minutes ago Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 7 hours ago EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026
Published on 08/03/2026 at 18:45, 7 hours 16 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 8 hours 16 minutes ago Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:40, 8 hours 21 minutes ago Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany